BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35947558)

  • 21. Mutation Signatures Depend on Epigenomic Contexts.
    Coleman N; De S
    Trends Cancer; 2018 Oct; 4(10):659-661. PubMed ID: 30292349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of coding and non-coding mutational hotspots in cancer genomes.
    Piraino SW; Furney SJ
    BMC Genomics; 2017 Jan; 18(1):17. PubMed ID: 28056774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatic mutation distributions in cancer genomes vary with three-dimensional chromatin structure.
    Akdemir KC; Le VT; Kim JM; Killcoyne S; King DA; Lin YP; Tian Y; Inoue A; Amin SB; Robinson FS; Nimmakayalu M; Herrera RE; Lynn EJ; Chan K; Seth S; Klimczak LJ; Gerstung M; Gordenin DA; O'Brien J; Li L; Deribe YL; Verhaak RG; Campbell PJ; Fitzgerald R; Morrison AJ; Dixon JR; Andrew Futreal P
    Nat Genet; 2020 Nov; 52(11):1178-1188. PubMed ID: 33020667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational landscape of RNA-binding proteins in human cancers.
    Neelamraju Y; Gonzalez-Perez A; Bhat-Nakshatri P; Nakshatri H; Janga SC
    RNA Biol; 2018 Jan; 15(1):115-129. PubMed ID: 29023197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromatin accessibility contributes to simultaneous mutations of cancer genes.
    Shi Y; Su XB; He KY; Wu BH; Zhang BY; Han ZG
    Sci Rep; 2016 Oct; 6():35270. PubMed ID: 27762310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local Determinants of the Mutational Landscape of the Human Genome.
    Gonzalez-Perez A; Sabarinathan R; Lopez-Bigas N
    Cell; 2019 Mar; 177(1):101-114. PubMed ID: 30901533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The topography of mutational processes in breast cancer genomes.
    Morganella S; Alexandrov LB; Glodzik D; Zou X; Davies H; Staaf J; Sieuwerts AM; Brinkman AB; Martin S; Ramakrishna M; Butler A; Kim HY; Borg Å; Sotiriou C; Futreal PA; Campbell PJ; Span PN; Van Laere S; Lakhani SR; Eyfjord JE; Thompson AM; Stunnenberg HG; van de Vijver MJ; Martens JW; Børresen-Dale AL; Richardson AL; Kong G; Thomas G; Sale J; Rada C; Stratton MR; Birney E; Nik-Zainal S
    Nat Commun; 2016 May; 7():11383. PubMed ID: 27136393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Candidate Cancer Driver Mutations in Distal Regulatory Elements and Long-Range Chromatin Interaction Networks.
    Zhu H; Uusküla-Reimand L; Isaev K; Wadi L; Alizada A; Shuai S; Huang V; Aduluso-Nwaobasi D; Paczkowska M; Abd-Rabbo D; Ocsenas O; Liang M; Thompson JD; Li Y; Ruan L; Krassowski M; Dzneladze I; Simpson JT; Lupien M; Stein LD; Boutros PC; Wilson MD; Reimand J
    Mol Cell; 2020 Mar; 77(6):1307-1321.e10. PubMed ID: 31954095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pan-cancer integrative analysis of whole-genome De novo somatic point mutations reveals 17 cancer types.
    Ghareyazi A; Kazemi A; Hamidieh K; Dashti H; Tahaei MS; Rabiee HR; Alinejad-Rokny H; Dehzangi I
    BMC Bioinformatics; 2022 Jul; 23(1):298. PubMed ID: 35879674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Procarcinogen Activation and Mutational Signatures Model the Initiation of Carcinogenesis in Human Urothelial Tissues In Vitro.
    Baker SC; Mason AS; Southgate J
    Eur Urol; 2020 Aug; 78(2):143-147. PubMed ID: 32349929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutational landscape and significance across 12 major cancer types.
    Kandoth C; McLellan MD; Vandin F; Ye K; Niu B; Lu C; Xie M; Zhang Q; McMichael JF; Wyczalkowski MA; Leiserson MDM; Miller CA; Welch JS; Walter MJ; Wendl MC; Ley TJ; Wilson RK; Raphael BJ; Ding L
    Nature; 2013 Oct; 502(7471):333-339. PubMed ID: 24132290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The evolutionary history of 2,658 cancers.
    Gerstung M; Jolly C; Leshchiner I; Dentro SC; Gonzalez S; Rosebrock D; Mitchell TJ; Rubanova Y; Anur P; Yu K; Tarabichi M; Deshwar A; Wintersinger J; Kleinheinz K; Vázquez-García I; Haase K; Jerman L; Sengupta S; Macintyre G; Malikic S; Donmez N; Livitz DG; Cmero M; Demeulemeester J; Schumacher S; Fan Y; Yao X; Lee J; Schlesner M; Boutros PC; Bowtell DD; Zhu H; Getz G; Imielinski M; Beroukhim R; Sahinalp SC; Ji Y; Peifer M; Markowetz F; Mustonen V; Yuan K; Wang W; Morris QD; ; Spellman PT; Wedge DC; Van Loo P;
    Nature; 2020 Feb; 578(7793):122-128. PubMed ID: 32025013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deciphering signatures of mutational processes operative in human cancer.
    Alexandrov LB; Nik-Zainal S; Wedge DC; Campbell PJ; Stratton MR
    Cell Rep; 2013 Jan; 3(1):246-59. PubMed ID: 23318258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Both cell autonomous and non-autonomous processes modulate the association between replication timing and mutation rate.
    Vardi-Yaacov O; Yaacov A; Rosenberg S; Simon I
    Sci Rep; 2023 Aug; 13(1):13143. PubMed ID: 37573368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SigsPack, a package for cancer mutational signatures.
    Schumann F; Blanc E; Messerschmidt C; Blankenstein T; Busse A; Beule D
    BMC Bioinformatics; 2019 Sep; 20(1):450. PubMed ID: 31477009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutagenesis by Microbe: the Role of the Microbiota in Shaping the Cancer Genome.
    Barrett M; Hand CK; Shanahan F; Murphy T; O'Toole PW
    Trends Cancer; 2020 Apr; 6(4):277-287. PubMed ID: 32209443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell cycle gene alterations associate with a redistribution of mutation risk across chromosomal domains in human cancers.
    Salvadores M; Supek F
    Nat Cancer; 2024 Feb; 5(2):330-346. PubMed ID: 38200245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pan-cancer analysis of gain-of-functional mutations to identify the common oncogenic signatures in multiple cancers.
    Wee Y; Liu Y; Bhyan SB; Lu J; Zhao M
    Gene; 2019 May; 697():57-66. PubMed ID: 30796966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers.
    Guo J; Zhou Y; Xu C; Chen Q; Sztupinszki Z; Börcsök J; Xu C; Ye F; Tang W; Kang J; Yang L; Zhong J; Zhong T; Hu T; Yu R; Szallasi Z; Deng X; Li Q
    Cancer Res; 2021 Aug; 81(16):4205-4217. PubMed ID: 34215622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex differences in oncogenic mutational processes.
    Li CH; Prokopec SD; Sun RX; Yousif F; Schmitz N; ; Boutros PC;
    Nat Commun; 2020 Aug; 11(1):4330. PubMed ID: 32859912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.